Evidence map›Paper›PMID 42323284›Full record

ArticleNature communications2026

A syntenic pangenome of Gardnerella reveals novel plasmids and phage, taxonomic boundaries, and species-level stratification of metabolic and virulence potential.

Heather K Bouzek, Martha A Zepeda-Rivera, Sujatha Srinivasan, Elliot M Lee, Susan M Strenk, Dakota S Jones, Elsa F McMahon, Tina L Fiedler, Marko Kostovski, Michael T France and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Heather K Bouzek *Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Martha A Zepeda-Rivera *Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-2408-8719
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-7267-3859
Elliot M LeeVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8323-2795
Susan M StrenkVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7845-2013
Dakota S JonesVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.
Elsa F McMahonVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.
Tina L FiedlerVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.
Marko KostovskiFaculty of Medicine, Institute of Microbiology and Parasitology, University Ss Cyril and Methodius in Skopje, Skopje, Macedonia.ORCID http://orcid.org/0000-0003-0590-9734
Michael T FranceCenter for Advanced Microbiome Research and Innovation, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Jacques RavelCenter for Advanced Microbiome Research and Innovation, Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-0851-2233
David N FredricksVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA. dfredric@fredhutch.org.ORCID http://orcid.org/0000-0003-2735-6800
Christopher D JohnstonDepartment of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. cdjohnston@mdanderson.org.ORCID http://orcid.org/0000-0002-6765-2383

Funding

The SyngenicDNA and μPOET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.R01DE027850 · NIDCR · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JOHNSTON, CHRISTOPHER D · 2017 to 2021
$4.9M
Fred Hutchinson Cancer Research Center (Hutchinson Center) Startup FundsNIDCR NIH HHS R01 DE027850U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) DE027850
6 · The paper itself

Abstract

Gardnerella species are key drivers of bacterial vaginosis (BV), a prevalent condition affecting nearly one in three women of reproductive age and associated with adverse reproductive outcomes. Despite decades of study, progress in defining Gardnerella diversity has been hindered by inconsistent taxonomy and poor-quality genomic resources. Here we sequenced 392 Gardnerella isolates spanning asymptomatic and BV-associated microbiota and integrated this collection with all publicly available genomes to create a curated, high-quality reference set of 312 genomes. We resolved 21 genomic lineages encompassing 11 species and 15 subspecies using phylogenomics, average nucleotide identity (ANI), digital DNA-DNA hybridization (dDDH) and assigned each a provisional taxonomic name. Long-read assemblies enabled construction of a syntenic Gardnerella pangenome, revealing lineage-specific repertoires of virulence, metabolic, and defense, including variable sialidases (NanH), vaginolysin, and amino-acid biosynthetic pathways alongside conserved genomic organization. Comparative methylome profiling uncovered restriction-modification system diversity suggesting barriers to genetic exchange. Finally, we identified native cryptic plasmids in Gardnerella, overturning the assumption that the genus lacks plasmids. Together, these results establish a complete genomic and functional framework for Gardnerella, providing a reproducible foundation for mechanistic and translational studies of BV and a model for resolving taxonomy and functional stratification in other urogenital-associated bacteria.

Indexed as

BacteriophagesGardnerella vaginalisGenome, BacterialPlasmidsSyntenyFemaleHumansNeuraminidasePhylogenyVaginosis, BacterialVirulenceNeuraminidase

Identifiers

PMID42323284
PMCPMC13483204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.